Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS.
Ching Serena KaoRebekah van BruggenJihye Rachel KimXiao Xiao Lily ChenCadia ChanJooyun LeeWoo In ChoMelody ZhaoClaudia ArndtKatarina MaksimovicMashiat KhanQiumin TanMichael D WilsonJeehye ParkPublished in: Nature communications (2020)
A missense mutation, S85C, in the MATR3 gene is a genetic cause for amyotrophic lateral sclerosis (ALS). It is unclear how the S85C mutation affects MATR3 function and contributes to disease. Here, we develop a mouse model that harbors the S85C mutation in the endogenous Matr3 locus using the CRISPR/Cas9 system. MATR3 S85C knock-in mice recapitulate behavioral and neuropathological features of early-stage ALS including motor impairment, muscle atrophy, neuromuscular junction defects, Purkinje cell degeneration and neuroinflammation in the cerebellum and spinal cord. Our neuropathology data reveals a loss of MATR3 S85C protein in the cell bodies of Purkinje cells and motor neurons, suggesting that a decrease in functional MATR3 levels or loss of MATR3 function contributes to neuronal defects. Our findings demonstrate that the MATR3 S85C mouse model mimics aspects of early-stage ALS and would be a promising tool for future basic and preclinical research.
Keyphrases
- amyotrophic lateral sclerosis
- early stage
- mouse model
- spinal cord
- crispr cas
- cell therapy
- single cell
- genome wide
- stem cells
- traumatic brain injury
- cerebral ischemia
- sentinel lymph node
- induced apoptosis
- type diabetes
- skeletal muscle
- genome editing
- squamous cell carcinoma
- gene expression
- cell proliferation
- adipose tissue
- metabolic syndrome
- small molecule
- radiation therapy
- bone marrow
- inflammatory response
- autism spectrum disorder
- insulin resistance
- lipopolysaccharide induced
- electronic health record
- signaling pathway
- deep learning
- brain injury
- subarachnoid hemorrhage